DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pilocarpine hydrochlorideis the generic ingredient in four branded drugs marketed by Alcon, Novartis, Akorn Inc, Somerset Theraps Llc, Aurobindo Pharma Ltd, Impax Labs, Innogenix, Lannett Co Inc, Perrigo Pharma Intl, and Concordia, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.
There are twelve drug master file entries for pilocarpine hydrochloride. Fourteen suppliers are listed for this compound.
Recent Clinical Trials for pilocarpine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Universidad de Murcia||Phase 1|
|Montefiore Medical Center||Phase 3|
|Maastricht University Medical Center||Early Phase 1|
Pharmacology for pilocarpine hydrochloride
|Drug Class||Cholinergic Receptor Agonist |
|Mechanism of Action||Cholinergic Agonists |
Cholinergic Muscarinic Agonists
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Akorn Inc||PILOCARPINE HYDROCHLORIDE||pilocarpine hydrochloride||SOLUTION;OPHTHALMIC||204398-001||Sep 27, 2017||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|Impax Labs||PILOCARPINE HYDROCHLORIDE||pilocarpine hydrochloride||TABLET;ORAL||077248-001||Mar 31, 2006||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Akorn Inc||PILOCARPINE HYDROCHLORIDE||pilocarpine hydrochloride||SOLUTION;OPHTHALMIC||204398-003||Sep 27, 2017||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|Lannett Co Inc||PILOCARPINE HYDROCHLORIDE||pilocarpine hydrochloride||TABLET;ORAL||077220-001||Oct 14, 2005||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Somerset Theraps Llc||PILOCARPINE HYDROCHLORIDE||pilocarpine hydrochloride||SOLUTION;OPHTHALMIC||210384-003||Nov 25, 2019||AT||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.